FitMi Plus Home Therapy for Stroke Patients

a study on Stroke

Summary

Eligibility
for people ages 18-85 (full criteria)
Location
at Irvine, California and other locations
Dates
study started
estimated completion
Principal Investigator
by David Reinkensmeyer, PhD

Description

Summary

The investigators will investigate the efficacy of a newly developed functional exercise device (FitMi Plus) for people in the chronic stage after a stroke compared to the FitMi Basic (i.e. without functional exercises). FitMi Plus combines objects commonly used during activities of daily living with sensors that can track and record the patient's direction and degree of movement as they perform specific functional tasks described on a computer.

Official Title

FitMi Plus: Smart Functional Modules for Practicing Activities of Daily Living After Stroke

Keywords

Cerebral Stroke Stroke FitMi Plus FitMi Basic

Eligibility

You can join if…

Open to people ages 18-85

  • Experienced 1 or more strokes >6 months prior to enrollment
  • Upper Extremity Fugl-Meyer Score >=15 and <=55 out of 66
  • Absence of moderate to severe upper extremity pain (<= 4 out of 10 on the visual-analog pain scale)
  • Ability to understand the instructions to operate FitMi products

You CAN'T join if...

  • Lack of concurrent severe medical problems
  • Lack of visual deficits
  • Lack of severe neglect or apraxia
  • No concurrent enrollment in another therapy study

Locations

  • Human Neuroperformance Laboratory at University of California Irvine accepting new patients
    Irvine California 926170000 United States
  • Rancho Research Institute, Inc accepting new patients
    Downey California 90242 United States

Lead Scientist at UC Irvine

  • David Reinkensmeyer, PhD
    Professor, Anatomy and Neurobiology, School of Medicine. Authored (or co-authored) 141 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Flint Rehabilitation Devices, LLC
ID
NCT03935425
Study Type
Interventional
Participants
Expecting 50 study participants
Last Updated
Contact us about this trial